147 related articles for article (PubMed ID: 22175130)
1. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 2. Salazosulfapyridine].
Kawai S
Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2910-7. PubMed ID: 22175130
[No Abstract] [Full Text] [Related]
2. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 1. Methotrexate].
Suzuki Y; Chinen N
Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2902-9. PubMed ID: 22175129
[No Abstract] [Full Text] [Related]
3. Use of sulfasalazine in rheumatic diseases.
Fuchs HA
Bull Rheum Dis; 1997 Nov; 46(7):3-4. PubMed ID: 9366125
[No Abstract] [Full Text] [Related]
4. [A survey of the doses of methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis].
Kawai S; Ochi T; Kondo H; Nishioka K; Nobuyuki N; Yoshino S
Ryumachi; 2002 Feb; 42(1):76-9. PubMed ID: 11925910
[No Abstract] [Full Text] [Related]
5. Efficacy of iguratimod
Nozaki Y; Inoue A; Kinoshita K; Funauchi M; Matsumura I
Mod Rheumatol; 2020 Mar; 30(2):249-258. PubMed ID: 30676812
[No Abstract] [Full Text] [Related]
6. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study.
Capell HA; Madhok R; Porter DR; Munro RA; McInnes IB; Hunter JA; Steven M; Zoma A; Morrison E; Sambrook M; Wui Poon F; Hampson R; McDonald F; Tierney A; Henderson N; Ford I
Ann Rheum Dis; 2007 Feb; 66(2):235-41. PubMed ID: 16926184
[TBL] [Abstract][Full Text] [Related]
7. Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.
Rains CP; Noble S; Faulds D
Drugs; 1995 Jul; 50(1):137-56. PubMed ID: 7588084
[TBL] [Abstract][Full Text] [Related]
8. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
Schnabel A; Gross WL
Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
[No Abstract] [Full Text] [Related]
9. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.
Wojciechowski J; Wiese MD; Proudman SM; Foster DJ; Upton RN
Br J Clin Pharmacol; 2015 May; 79(5):777-88. PubMed ID: 25394211
[TBL] [Abstract][Full Text] [Related]
10. [Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment; 2. Antirheumatic agents, 1) non-biologic agents].
Tamura N
Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2873-9. PubMed ID: 23214096
[No Abstract] [Full Text] [Related]
11. [Methotrexate and salazosulfapyridine in the long-term treatment of rheumatoid arthritis].
Ichikawa Y; Shinozawa T; Yoshida T; Kameda H; Suzuki Y; Kawai S; Yamada H; Matsuda T
Ryumachi; 1995 Aug; 35(4):663-70. PubMed ID: 7482063
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in the management of rheumatoid arthritis.
Murphy NG
Del Med J; 1992 Apr; 64(4):257-64. PubMed ID: 1352263
[No Abstract] [Full Text] [Related]
13. [Three joints swollen, blood sedimentation increased. Methotrexate to be given immediately?].
Burmester GR
MMW Fortschr Med; 2004 Sep; 146(37):10. PubMed ID: 15887693
[No Abstract] [Full Text] [Related]
14. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
Borg AA
Br J Rheumatol; 1995 Nov; 34(11):1097-8. PubMed ID: 8542218
[No Abstract] [Full Text] [Related]
15. Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis.
Haibel H; Specker C
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S159-63. PubMed ID: 19822065
[TBL] [Abstract][Full Text] [Related]
16. Treatment of rheumatoid arthritis.
Schinagl EF; Strauss PC
N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778594
[No Abstract] [Full Text] [Related]
17. [DMARDs (disease-modifying antirheumatic drugs)].
Tanaka E; Yamanaka H
Nihon Rinsho; 2013 Jul; 71(7):1199-206. PubMed ID: 23961667
[TBL] [Abstract][Full Text] [Related]
18. How do second-line agents work?
Choy E; Kingsley G
Br Med Bull; 1995 Apr; 51(2):472-92. PubMed ID: 7552077
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacogenomics of antirheumatic drugs and personalized medicine for rheumatoid arthritis].
Taniguchi A; Urano W; Tanaka E; Kamatani N
Nihon Rinsho; 2007 Feb; 65(2):371-9. PubMed ID: 17302286
[TBL] [Abstract][Full Text] [Related]
20. Treatment of rheumatoid arthritis.
Zurier RB; DeMarco DM; Liu NY
N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778595
[No Abstract] [Full Text] [Related]
[Next] [New Search]
